|
Inside This Issue - Opinion
In the mass retailing firmament, the retailer is king. For industry suppliers, a primary objective is getting close to the retail merchants who make the key decisions affecting their products. If a new survey of pharmaceutical executives whose companies account for more than 40% of the industry’s global revenue is any indication, an era characterized by a remarkable level of innovation may be drawing to a close.
|